MiNK is pleased to announce the appointment of Yekaterina Chudnovsky as Board Observer. An accomplished attorney and venture investor, Ms. Chudnovsky brings a wealth of experience as a dedicated patient advocate and supporter of medical research. She currently serves as the Chairperson of the GI Research Foundation at the University of Chicago Digestive Diseases Center.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INKT:
- MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer
- MiNK to Provide Corporate Update and First Quarter 2024 Financial Report
- MiNK Therapeutics Announces Promising Preclinical Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR
- MiNK announces presentation of MiNK-215 data at AACR meeting
- MiNK Reports Fourth Quarter and Year-End 2023 Results
